Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Denosumab

Brand: Xgeva®
NICE TA: 265
Indication: Bone metastasis from solid tumours (NICE TA265)
Disease category: Endocrine system
Commissioning responsibility: CCG
PbR excluded: No

Background

LMMG is adopting the local decision made prior to April 2013

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Red

Red

Red

Red

Red

Red